Literature DB >> 21764185

Design and synthesis of 2-phenylimidazo[1,2-a]pyridines as a novel class of melatonin receptor ligands.

Saïd El Kazzouli1, Amaury Griffon du Bellay, Sabine Berteina-Raboin, Philippe Delagrange, Daniel-Henry Caignard, Gérald Guillaumet.   

Abstract

A novel class of imidazo[1,2-a]pyridines as melatonin receptor ligands is designed and synthesized. The affinities of 3-(6-methoxy-2-phenylimidazo[1,2-a]pyridine-3-yl)-N-methyl-propionamide 8, N-[2-(6-methoxy-2-phenylimidazo[1,2-a]pyridine-3-yl)-ethyl]-acetamide 13 and N-(1-hydroxy-3-(5-methoxy-2-phenyl-1H-indol-3-yl)propan-2-yl)acetamide 18 are evaluated for binding on melatonin receptors. Compound 8 present good selectivity for MT(2) over MT(1) (MT(1)/MT(2) = 19) and compound 13 have good affinities for both MT(1) (Ki :28 nM) and MT(2) (Ki : 8 nM).
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21764185     DOI: 10.1016/j.ejmech.2011.06.030

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  Synthesis and antibacterial evaluation of new, unsymmetrical triaryl bisamidine compounds.

Authors:  Son T Nguyen; John D Williams; Michelle M Butler; Xiaoyuan Ding; Debra M Mills; Tommy F Tashjian; Rekha G Panchal; Susan K Weir; Chaeho Moon; Hwa-Ok Kim; Jeremiah A Marsden; Norton P Peet; Terry L Bowlin
Journal:  Bioorg Med Chem Lett       Date:  2014-06-12       Impact factor: 2.823

2.  Original Design of Fluorescent Ligands by Fusing BODIPY and Melatonin Neurohormone.

Authors:  Jérémy Thireau; Justine Marteaux; Philippe Delagrange; Francois Lefoulon; Laurence Dufourny; Gérald Guillaumet; Franck Suzenet
Journal:  ACS Med Chem Lett       Date:  2013-11-20       Impact factor: 4.345

3.  Fluorescent property of 3-hydroxymethyl imidazo[1,2-a]pyridine and pyrimidine derivatives.

Authors:  Stephania Velázquez-Olvera; Héctor Salgado-Zamora; Manuel Velázquez-Ponce; Elena Campos-Aldrete; Alicia Reyes-Arellano; Cuauhtémoc Pérez-González
Journal:  Chem Cent J       Date:  2012-08-07       Impact factor: 4.215

4.  A One Pot Synthesis of Novel Bioactive Tri-Substitute-Condensed-Imidazopyridines that Targets Snake Venom Phospholipase A2.

Authors:  Nirvanappa C Anilkumar; Mahalingam S Sundaram; Chakrabhavi Dhananjaya Mohan; Shobith Rangappa; Krishna C Bulusu; Julian E Fuchs; Kesturu S Girish; Andreas Bender; Kanchugarakoppal S Rangappa
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

Review 5.  Melatonergic drugs in development.

Authors:  Alessia Carocci; Alessia Catalano; Maria Stefania Sinicropi
Journal:  Clin Pharmacol       Date:  2014-09-18

6.  New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.

Authors:  Saioa Ancizu; Nerea Castrillo; Silvia Pérez-Silanes; Ignacio Aldana; Antonio Monge; Philippe Delagrange; Daniel-Henry Caignard; Silvia Galiano
Journal:  Molecules       Date:  2012-06-25       Impact factor: 4.411

7.  Intramolecular H-bonding interaction in angular 3-π-EWG substituted imidazo[1,2-a]pyridines contributes to conformational preference.

Authors:  Manuel Velázquez-Ponce; Héctor Salgado-Zamora; Hugo A Jiménez-Vázquez; Maria Elena Campos-Aldrete; Rogelio Jiménez; Humberto Cervantes; Taibi Ben Hadda
Journal:  Chem Cent J       Date:  2013-01-31       Impact factor: 4.215

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.